Female sex, good performance status, and bevacizumab‐induced hypertension associated with survival benefit in Asian patients with recurrent glioblastoma treated with bevacizumab

Abstract

We showed good responses using bevacizumab and the progression-free survival and overall survival were comparable with those previously reported. The adverse events of bevacizumab in our study were generally acceptable and manageable. Female sex, good performance status, and grade 3 posttreatment hypertension were suggested to be associated with survival benefits.